1. Pregnancy Loss and Cardiovascular Diseases in Women: Recent Findings and Potential Mechanisms

   • Mette Marie Babiel Schmidt Petersen
   • Tanja Schlaikjær Hartwig
   • Henriette Svarre Nielsen

   Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 16 November 2022 Pages: 889 - 899

   

2. Social Media and Cardiovascular Health: Implications for Women

   • Rachel E. Goodman
   • Morgan Lamberg
   • Sherry-Ann Brown

   Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 28 November 2022 Pages: 901 - 913

   

3. CETP Inhibitors: Should We Continue to Pursue This Pathway?

   • Stephen J. Nicholls
   • Adam J. Nelson

   Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors) 21 November 2022 Pages: 915 - 923

   

4. Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes

   • Kunal K. Jha
   • Rishav Adhikari
   • Michael J. Blaha

   Evidence-Based Medicine, Clinical Trials and Their Interpretations​ (K. Nasir, Section Editor) 24 November 2022 Pages: 925 - 937

   

5. A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke

   • Thomas B. H. Potter
   • Jonika Tannous
   • Farhaan S. Vahidy

   Evidence-Based Medicine, Clinical Trials and Their Interpretations​ (K. Nasir, Section Editor) Open access 14 November 2022 Pages: 939 - 948

   

6. Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology

   • Nathan D. Wong

   Evidence-Based Medicine, Clinical Trials and Their Interpretations​ (K. Nasir, Section Editor) Open access 14 November 2022 Pages: 949 - 957

   

7. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis

   • Farzahna Mohamed
   • Brett S. Mansfield
   • Frederick J. Raal

   Genetics and Genomics (R.A. Hegele, Section Editor) 11 November 2022 Pages: 959 - 967

   

8. The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular Health

   • Penny M. Kris-Etherton
   • Philip A. Sapp
   • Olivia Lawler

   Nutrition (K. Petersen, Section Editor) Open access 24 November 2022 Pages: 969 - 980

   

9. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

   • Melody Hermel
   • Megan Pelter
   • Salim S. Virani

   Reviews and Scientific Meetings and New Research Implications (S. Virani, Section Editor) 08 November 2022 Pages: 981 - 993

10. PCSK9 Inhibition and Risk of Diabetes: Should We Worry?

    • Stefano Carugo
    • Cesare R. Sirtori
    • Massimiliano Ruscica

    Cardiometabolic Disease and Treatment (R. Santos, Section Editor) Open access 16 November 2022 Pages: 995 - 1004